The 17 references in paper A. Ehrlich D., А. ЭРЛИХ Д. (2015) “МЕСТО ТИКАГРЕЛОРА В НОВЫХ РЕКОМЕНДАЦИЯХ ПО ЛЕЧЕНИЮ ПАЦИЕНТОВ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ // PLACE OF TICAGRELOR IN THE NEW RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME” / spz:neicon:aterotromboz:y:2015:i:2:p:58-65

1
Libby P. Current concepts of pathogenesis of the acute coronary syndromes. Circulation,2001. 104: 365–72.
(check this in PDF content)
2
ISIS-2 collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both, or nether among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet,1988. 332 (8607): 349–360.
(check this in PDF content)
3
The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. N Engl J Med, 2001. 345: 494–502.
(check this in PDF content)
4
Husted S, Emanuelsson H, Heptinstall S et al. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12antagonist AZD6140 with aspirin in patients with atherosclerosis: a doubleblind comparison to clopidogrel with aspirin. Eur Heart J., 2006. 27: 1038–1047.
(check this in PDF content)
5
Gurbel PA, Bliden KP, Butler K, et al Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation, 2009. 22. 120(25): 2577–85.
(check this in PDF content)
6
Wallentin L, Backer RC, Budaj A, et al. Ticagrelor versus clopidorel in patients with acute coronary syndromes. N Engl J Med, 2009. 361: 1045–57.
(check this in PDF content)
7
Lindholm D, Varenhorst C, Cannon CP, et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J, 2014. 35(31): 2083–2093.
(check this in PDF content)
8
Steg PG, James S, Harrington RA, et al. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation, 2010. 122(21): 2131–41.
(check this in PDF content)
9
Montaescot G, van’t Hof AW, Lapostolle F, et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med, 2014. 371:
(check this in PDF content)
10
6–1027. 10. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherotrombotic events. N Engl J Med,2006.354: 1706–17.
(check this in PDF content)
11
Bhatt DL, Flather MD, Hacke W, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol, 2007. 49: 1982–8.
(check this in PDF content)
12
Bonaca MP, Bhatt DL, Braunwald E, et al. Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin– Thrombolysis in Myocardial Infarction 54 (PEGASUSTIMI 54) trial. Am Heart J, 2014. 167: 437–44.
(check this in PDF content)
13
ESC Guidelines for the management of acute coronary syndromes in patients presenting without STsegment elevation. Eur Heart J, 2011. 32, 2999–3054.
(check this in PDF content)
14
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. doi:10.1093/eurheartj/ehv320.
(check this in PDF content)
15
ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation. Eur Heart J, 2012. 33, 2569–2619.
(check this in PDF content)
16
Эрлих А.Д., Мацкеплишвили С.Т., Грацианский Н.А., Бузиашвили Ю.И. и все участники московского регистра ОКС. Первый московский регистр острого коронарного синдрома: характеристика больных, лечение и исходы за время пребывания в стационаре. Кардиология, 2013. 12: 4–13.
(check this in PDF content)
17
Zeymer U, Hochadel M, Elsaesser A, et al. Use of clopidogrel, prasugrel and ticagrelor in patients with NSTE-ACS undergoing PCI in clinical practice: results of the ALKK-PCI registry. J Am Coll Cariol, 2015. 65(10_S).
(check this in PDF content)